Exploring the Treatment Landscape for Treatment-Resistant Depression

Megan Maroney, PharmD, BCPP, leads a discussion about the treatment landscape of TRD.

The incidence and prevalence of TRD is explored.

Medical experts discuss the risk factors associated with TRD.

Key opinion leaders illustrate treatment strategies for patients diagnosed with TRD.

The panelists provide an overview of the treatment model for treating patients with treatment-resistant depression.

An in-depth assessment of treatment-resistant depression therapies is explored.

Ms Maroney drives a conversation regarding response to treatment-resistant depression.

Panelists address factors driving clinical inertia in treatment-resistant depression.

The panel of experts highlight the patient journey commonly experienced in search of a treatment-resistant depression diagnosis.

Michael Edward Thase, MD, leads a discussion surrounding an array of challenges impacting patients with treatment-resistant depression.

Collaboration between providers and payers can help remove the stigmas associated with mental health disorders.

The panelists provide key takeaways from this discussion surrounding treatment-resistant depression.